Literature DB >> 29326831

Management of Complications in Anticoagulated Patients with Atrial Fibrillation.

George D Katritsis1, Demosthenes G Katritsis2.   

Abstract

Oral anticoagulation is mandatory for patients at high risk of thromboembolism, but the risk of bleeding should also be taken into account. Direct oral anticoagulants are now recommended for non-valvular AF as a potential alternative to warfarin. In this article we discuss methods to assess the anticoagulant effect of these agents, specific and general antidotes, and management of complications such as embolic and haemorrhagic stroke, and significant bleeding.

Entities:  

Keywords:  Atrial fibrillation; anticoagulation; bleeding; ischaemic stroke

Year:  2017        PMID： 29326831      PMCID： PMC5739886          DOI： 10.15420/aer.2017.23.1

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  76 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Idarucizumab: The Antidote for Reversal of Dabigatran.

Authors:  John W Eikelboom; Daniel J Quinlan; Joanne van Ryn; Jeffrey I Weitz
Journal:  Circulation       Date:  2015-12-22       Impact factor: 29.690

Review 3.  How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring.

Authors:  Gregory Y H Lip
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

Review 4.  Stroke prevention in atrial fibrillation: a systematic review.

Authors:  Gregory Y H Lip; Deirdre A Lane
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

5.  The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.

Authors:  N Sengupta; J D Feuerstein; V R Patwardhan; E B Tapper; G A Ketwaroo; A M Thaker; D A Leffler
Journal:  Am J Gastroenterol       Date:  2014-12-16       Impact factor: 10.864

6.  Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Authors:  Stuart J Connolly; Janice Pogue; John Eikelboom; Gregory Flaker; Patrick Commerford; Maria Grazia Franzosi; Jeffrey S Healey; Salim Yusuf
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

7.  Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Truman J Milling; John W Eikelboom; C Michael Gibson; John T Curnutte; Alex Gold; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Shelly Goodman; Janet Leeds; Brian L Wiens; Deborah M Siegal; Elena Zotova; Brandi Meeks; Juliet Nakamya; W Ting Lim; Mark Crowther
Journal:  N Engl J Med       Date:  2016-08-30       Impact factor: 91.245

8.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690

9.  Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.

Authors:  Alexander Niessner; Juan Tamargo; João Morais; Lorenz Koller; Sven Wassmann; Steen Elkjær Husted; Christian Torp-Pedersen; Keld Kjeldsen; Basil S Lewis; Heinz Drexel; Juan Carlos Kaski; Dan Atar; Robert F Storey; Gregory Y H Lip; Freek W A Verheugt; Stefan Agewall
Journal:  Eur Heart J       Date:  2017-06-07       Impact factor: 29.983

10.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Colin P Derdeyn; José Biller; Christopher S Coffey; Brian L Hoh; Edward C Jauch; Karen C Johnston; S Claiborne Johnston; Alexander A Khalessi; Chelsea S Kidwell; James F Meschia; Bruce Ovbiagele; Dileep R Yavagal
Journal:  Stroke       Date:  2015-06-29       Impact factor: 10.170
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.